Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma

Clinical trial NCT07611149 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07611149
Sponsor: Kure Cells, INC
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse Multiple Myeloma, Refractory

Start date: 2026-09-01
Primary completion: 2028-09-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.